svenska

Key events during the year

2016

Quarter 1

  • Distribution of the shares in the subsidiary Infant Bacterial Therapeutics (IBT).
  • New meta-analysis confirms effectiveness of BioGaia Protectis on colic.
  • Meta-analysis confirms effectiveness of BioGaia Prodentis on periodontal disease.

Quarter 2

  • Agreement for the sale of BioGaia Prodentis in Hong Kong.
  • Additional meta-analysis confirms effectiveness of BioGaia Protectis on colic.
  • Publication of study showing positive effects of BioGaia Protectis in treatment of abdominal pain in children.

Quarter 3

  • Publication of study showing that BioGaia Prodentis reduces pregnancy gingivitis.
  • Agreement for the sale of drops, tablets and oral rehydration solution in Kenya, Nigeria and Ghana.

Quarter 4

  • Major new agreements for the sale of BioGaia’s probiotic products in Japan.
  • BioGaia makes further investment in MetaboGen.

Key events after the end of 2016

  • Agreement for the sale of BioGaia’s products in Thailand.

BioGaia year